28 October 2024 | Pre-Congress Workshops | Catalonia Barcelona Plaza
29-31 October 2024 | Main Congress Days | Fira de Barcelona Montjuïc
Attendees
Speakers
Exhibitors
Days
1 to 1 Partnering Meetings
Networking Connections
The World Vaccine Congress Europe is the largest and most established European meeting on vaccine R&D
Covering Clinical Development, Bioprocessing & Manufacturing, Cancer Immunotherapy and much more
150+ leading solution providers from across the globe, featuring new ways of thinking and novel partnerships to generate solutions
Networking is at the heart of World Vaccine Congress Europe. Our congress allows you to connect directly with thousands of vaccine experts across 4 days of built-in 1-2-1 networking
Dr. Keirstead is an internationally known stem cell expert and has led therapy development for late stage cancers, immune disorders, motor neuron diseases, spinal cord injury and retinal diseases. He is the CEO of AIVITA Biomedical. He was previously CSO of Caladrius which acquired California Stem...
Dr. Veterinary Medicine, virologist, global networking in human and animal health, vaccines and diagnostics, global disease control, one health, public affairs with EU, WHO, Asian and African authorities and experienced in vaccine translational development.Achievements in brief: Discovery of H1N1...
Dr. Ed Kelley is the Chief Global Health Officer at ApiJectHe recently left his position as the World Health Organization’s Director of Integrated Health Services, where he helped lead the organization’s COVID-19 response, creating WHO’s first public-private collaboration working directly with the...
Antonio Garcia Maldonado is an Principal at SIF. He works on international investments with a focus on biotech in Europe and Israel, and tech-enabled service/product delivery in South Asia and Sub-Saharan Africa. Prior to joining the foundation, Antonio worked in the investment banking division at...
Francesco Pappalardo was born in Catania on 11 March 1975. He graduated in Computer Science with 110/110 cum laude on 2000 at the University of Catania; after graduating, in 2004 he obtained the title of Doctor of Philosophy (PhD) in Computer Science. From 2004 to 2011 he was a research fellow at...
Dr Ewer is an expert in the human immune response to vaccination and specialises in understanding how immunity translates into protective efficacy. She undertook her PhD on the immunology of T cell responses to TB and co-developed a diagnostic assay for the early detection of TB infection. She has...
Dr. Lenny Moise, VP Research, manages client projects and scientific development of the SeromYx Systems Serology platform for clinical research and drug discovery in infectious disease, immuno-oncology, autoimmunity and neurology. Prior to joining SeromYx, Lenny was Director of Vaccine Research at...
A veterinarian by training, after completing my PhD at The Pirbright Institute in 1993 I became Head of the International FMD Vaccine Bank and held the position for 4 years. I moved to Pfizer AH in Sandwich, England in 1997 and eventually became Director of Biologicals Research for Europe, Africa...
Ingrid de Visser - Kamerling (1975) graduated in Medical Biology from Leiden University in 1998. She subsequently worked at CHDR as a project leader and PhD student. She obtained her PhD from Leiden University in 2003 and became a registered clinical pharmacologist in 2005. From 2004 to 2007, she...
Professor Anne Moore holds a joint position between the School of Biochemistry and Cell Biology, UCC and the National Institute of Bioprocessing Research and Training (NIBRT). She brings to this joint appointment a wealth of expertise in immunology, bioprocessing, and vaccine development. Professor ...
Dr. Irina Meln is the Head of Innovation at the European Vaccine Initiative (EVI) in Heidelberg, Germany. She is responsible for developing, securing funding for, and leading large collaborative projects that leverage public-private partnerships to drive innovation in the vaccine field. With over...
Chris joined Biologics Consulting as a Senior Consultant in 2015 after 2 years as an independent CMC consultant and more than 25 years of experience in the development, manufacturing, and quality control of clinical and commercial biopharmaceutical products, as well as IVDs. Fourteen of those years ...
Professor Munir Iqbal is the Head of the Avian Influenza and Newcastle Disease group at The Pirbright Institute and a visiting professor at the Royal Veterinary College, London. Munir obtained Veterinary Medicine and MPhil degrees in Pakistan and a PhD in Biotechnology at Imperial College London in ...
Tim Peterson is Associate Director, Product and Process Development at Kindeva Drug Delivery’s Woodbury, MN, headquarters, guiding Kindeva’s innovations in complex drug delivery. He has been developing and scaling up transdermal and microneedle-enabled drug delivery systems for over 30 years. Prior ...
Dr. Marco Pravetoni holds the Rick L. Seaver Endowed Professorship in Brain Health, and he is a Professor of Psychiatry and Behavioral Sciences, Professor of Pharmacology, and Director of the Center for Medication Development for Substance Use Disorders and Overdose at the University of Washington...
Dr. Uchida is a professor at Tokyo Medical and Dental University and the Chief Medical Officer of Crafton Biotechnology. He leads interdisciplinary research that bridges the fields of medicine and engineering. After graduating from the University of Tokyo Medical School, Dr. Uchida began his career ...
Dr Thomas Waite is the Deputy Chief Medical Officer leading on health protection. His role covers emergency response and preparedness, infectious diseases, vaccines and therapeutics. Dr Waite is a consultant epidemiologist and completed his clinical and public health training in south Wales. He is ...
Nico holds a degree Business Engineering and obtained a PhD in Operations Research and Operations Management from KU Leuven in 1996. As full professor at KU Leuven, he is holder of the GSK Research Chairs on Access-to-Medicines, the Janssen Pharmaceutica Research Chair on Pandemic Preparedness and...
Dr. de Jongh has a M.Sc. in Chemical Engineering from the University of Stellenbosch, South Africa and was awarded a doctorate in Biotechnology from the Technical University of Denmark (DTU). Furthermore, he was awarded an affiliated associate professorship at DTU in 2017. Dr. de Jongh has 18 years ...
Marie-Louise Lunn is Global Product Manager at Novo Nordisk Pharmatech with on enzymes for bioprocessing. She holds a Ph.D. in molecular biology and drug discovery from the University of Copenhagen, Denmark. After working as a postdoctoral researcher at the Salk Institute for Biological Studies in...
Isabel Oliver is the Director General of Science and Research (Chief Scientific Officer) at the UK Health Security Agency (UKHSA). She is a medical epidemiologist who until recently was the Director, National Infection Service of Public Health England leading the specialist epidemiology teams and...
About Dr. Karina Pasquevich: Dr. Karina Pasquevich is an Argentinean scientist with more than 20 years of experience in the field of Immunology. Her journey in this discipline began in 2003, and since then, she has been working in immunology of infectious diseases, vaccine and adjuvant development ...
Chief scientific officer since 2019, responsible for the overall scientific company strategy. Heading a team of innovators taskes with pushing thte boundaries of cell-free protein espression accelerating biotherapeutic development. Biologist/Immunologist by training with over 25 years’ experience...
Emilie Karafillakis is an Assistant Professor and European Director of the Vaccine Confidence Project (VCP), with appointments at the London School of Hygiene and Tropical Medicine as well as at the University of Antwerp (European office of the VCP).She has around 10 years of experience as a social ...
Sibilia Quilici joined Vaccines Europe as Executive Director in January 2021. Vaccines Europe (VE) represents major innovative research-based vaccine companies operating in Europe, including small and medium-sized enterprises. Together with its direct membership of 14 leading vaccine companies and ...
Avencia Sánchez-Mejías is CEO and co-Founder of Integra Therapeutics, a global leader in creating next generation gene writing tools to make advanced therapies safer and more effective. Avencia has experience in business management and transferring technology of excellence from academia to industry ...
Amy Shurtleff holds a Ph.D. in Viral Pathogenesis and is Head of Animal Models in the Laboratory Research and Innovations Department in the Division of Research and Development at the Coalition for Epidemic Preparedness Innovations (CEPI). Dr Shurtleff administers research programs for preclinical...
Thomas is Director of Bioinformatics and AI/ML at Evaxion and is currently leading the development of Evaxion’s AI-Immunology™ platform for designing vaccines against cancer and infectious diseases. Prior to joining Evaxion in 2016, Thomas acquired his PhD in Immunological Bioinformatics from the...
Cari Kessing has been serving as a Director in Vaccines Lab Operations at IQVIA Laboratories since 2022. Following her doctoral/postdoctoral training at Emory University, Vaccines and Gene Therapy Institute and Scripps Institute, she transitioned to the Vaccines industry at GSK, accruing extensive...
Professor Lucy Chappell is Chief Scientific Adviser to the Department of Health and Social Care and Chief Executive Officer of the National Institute for Health and Care Research (NIHR), the UK’s largest funder of health and care research. The Chief Scientific Adviser has overall responsibility for ...
Mr. Enrique Mañán, a distinguished Hubert Humphrey Service to America Award winner, serves as the Chief of Staff for the Division of Contract Management and Acquisitions (CMA) within the Center for Biomedical Advanced Research and Development Authority (BARDA). In this pivotal role, he ensures that ...
Jane True is Vice President for mRNA Commercial Strategy and Innovation and Global Pandemic Security Lead at Pfizer, directing a team responsible for mRNA platform, pipeline, and product strategy. True also leads the charge on preparing the global community for future pandemics and achieving...
Mario Barro is the CEO of GIVAX, a vaccine development startup dedicated to eliminating the burden of preventable GI tract infections in children and adults. As the CEO, Mario is leading the development of innovative vaccine solutions designed to address critical unmet medical needs. In addition to ...
Jonathan Heeney is Head of The Laboratory of Viral Zoonotics. Research focuses on cross species transmissions of viruses, and the co-evolution of viruses and their hosts including the evolution of immune mechanisms of disease protection in naturally infected but disease resistant species. Not only...
Nektaria Karavas is the Global Director of Business Development for Nasal Vaccines, Antivirals and Immuno-stimulants at Aptar Pharma. Ms. Karavas joined Aptar Pharma in 2004 and has held various commercial roles executing long-term strategy within key customer and global accounts in North America...
Xinhao Ye has 15 years of vaccine development experience with growing responsibilities in research, development, and commercialization of different types of vaccines, including polysaccharide conjugate vaccines, recombinant protein, and mRNA-based vaccines. Before joining WuXi Vaccines, he worked...
Dr. Ballmann is a veterinary virologist with over a decade of experience at Batavia Biosciences. As the Associate Director of the Viral Vector and Vaccine Development Department, she leads innovative programs focused on the development and production of viral vaccines and viral vectors. Beyond her...
Dr. Zeil Rosenberg is responsible for vaccine development at Tonix Pharmaceuticals. Previous to this, he was Therapeutic Area Head for Vaccines at PPD (AES) , Worldwide Business Leader for Vaccines at Becton Dickinson (BD), and resident National Immunization Advisor in Indonesia through USAID and...
Maria is the Director of the Vaccine Innovation Pathway at the National Institute for Health and Care Research (NIHR), bringing over 20 years of experience in driving strategy and innovation in health and life sciences research services. She has extensive experience collaborating with a wide range...
Dr. Brander has been studying cellular immunity to different viral infections, including HIV, HCV and tumorigenic human herpesviruses, such as EBV and KSHV. He has published more than 250 peer-reviewed articles, many focusing on properties of viral-epitope specific T cells and how T cell receptor ...
Dr Rosaria Esposito is a Field Scientist at bioMérieux. She provides application and scientific support to VaxArray® users in Europe. The VaxArray® platform is developed and commercialized by the company InDevR (Boulder, CO), for which bioMérieux is the exclusive distributor in Europe. Dr Esposito...
Andrew Goldsborough is an accomplished inventor and founder of RNAssist with over 25 years of experience in the development of stabilization technologies for the life sciences. He has successfully founded and led three biotechnology companies, each specializing in advanced solutions for stabilizing ...
Dr. Huebner has over 30 years of experience in biologics development with a large focus on vaccines while working in large pharma companies, government agencies, and contract research organizations. At LBG, Dr. Huebner supports both commercial and U.S. Government-funded programs as a subject matter ...
Randy Lacey, PhD, completed his bachelor’s degree in biology and chemistry at Austin Peay State University prior to completing his doctoral studies in biochemistry and molecular biology at the University of Tennessee. Following his PhD studies, Randy worked as a postdoctoral research fellow first...
Dr. Romain Micol has been President, co-founder, and Chief Executive Officer of Combined Therapeutics since 2016. Previously, he held several positions across the Institut Mérieux group: ABL Inc (USA), Shantha Biotechnics (India), and Transgene (China and France). Dr. Micol helped to set up...
Marta G. Murreddu is a seasoned professional in clinical research, virology, and project management. She successfully oversaw clinical trials, managed client communications, and ensured adherence to timelines and budgets. From 2021 to 2023, she led Clinical Virology Services at Viroclinics, where...
Dr. Nitin M. Shetty is the CTO and Deputy Test Facility Manager at Bioneeds, a preclinical CRO in India recognized for its OECD GLP certification and USFDA audits. With over 30 years of industry experience, he specializes in the preclinical development of vaccines, biopharmaceuticals, and medical...
Join our mailing list to receive exclusive content and offers.
By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.